Try a new search

Format these results:

Searched for:

in-biosketch:true

person:husais06

Total Results:

172


Association between out-of-sequence allocation and deceased donor kidney nonuse across organ procurement organizations

Adler, Joel T; Cron, David C; Kuk, Arnold E; Yu, Miko; Mohan, Sumit; Husain, S Ali; Parast, Layla
Out-of-sequence (OOS) kidney allocation has become increasingly prevalent since 2021. We examined the relationship between organ procurement organization (OPO) OOS allocation frequency and kidney nonuse rates. Among 57 OPOs between March 2021 and December 2023, we analyzed trends in OOS utilization and its association with kidney nonuse rates. There was significant variability in OOS use across OPOs, with some allocating over 20% of kidneys out-of-sequence over the entire period. An absolute increase of 1 SD (12.8%) of OOS allocation was modestly associated with a reduction in kidney nonuse rates (incidence risk ratio = 0.98; P = .04). Donor characteristics, particularly older age, donation after circulatory death, and high kidney donor profile index, were the strongest predictors of nonuse. While OOS allocation may mitigate logistical challenges, other strategies may be more effective at reducing the nonuse rate.
PMID: 39971132
ISSN: 1600-6143
CID: 5868112

Financial Toxicity in ESKD

Maclay, Lindsey M; Woodward, Kyle; Strohmayer, Natalie; Yu, Miko E; Mohan, Sumit; Huml, Anne M; Husain, Syed Ali
BACKGROUND:Patients with kidney failure require treatments that are demanding and time-intensive, potentially interfering with employability and leading to indirect costs. We sought to characterize the prevalence of, and risk factors for financial toxicity among patients with kidney failure. METHODS:We conducted a cross-sectional survey study of 112 participants with kidney failure at a large, urban, academic medical center. Financial toxicity was assessed via a survey which included the validated CoST tool as well as additional items to evaluate self-reported changes to material conditions and financial coping behaviors. Participants were grouped according to kidney replacement therapy modality (dialysis, transplant after dialysis, or preemptive transplant) Descriptive statistics were used to summarize demographic and clinical characteristics of the study population and to compare those with above-median vs below-medial CoST scores, and by modality of kidney replacement therapy. RESULTS:Median CoST score was 17 with 71% of participants experiencing at least mild financial toxicity. Participants experiencing financial toxicity were less likely to have White race, and more likely to be receiving dialysis. Over half of participants reported reduction in employment (61%) or income (57%) following kidney failure onset with the greatest likelihood of these among participants with any dialysis. CONCLUSIONS:Adults with kidney failure experience significant financial toxicity as measured by the CoST score and report significant negative changes in employment and income. Although this toxicity persists through many stages of treatment, treatment modality may impact financial burdens experienced by patients with kidney failure.
PMID: 40471680
ISSN: 2641-7650
CID: 5868172

Association of the initial implementation of continuous distribution allocation policy with outcomes for lung transplant candidates by blood type

Schold, Jesse D; Hoffman, Jordan R H; Mohan, Sumit; Gray, Alice L; Lopez, Rocio; Arrigain, Susana; Brosi, Deena; LaVanchy, Ryan; Husain, S Ali; Yu, Miko; Pomfret, Elizabeth A
On March 9, 2023, allocation of donor lungs in the United States changed to continuous distribution (CD). Initial implementation of policy was flawed due to a programming error affecting priority of candidates by blood type. Although this issue has been identified and addressed, the impact of initial policy implementation on blood type-O candidates has not been rigorously evaluated. We used data from the Scientific Registry of Transplant Recipients to evaluate candidate (n = 4738) and recipient (n = 4437) outcomes following CD policy implementation. Using cumulative incidence plots accounting for competing risks and multivariable Cox models, incidence of transplantation prepolicy was similar by blood type (8-month incidence 81.0% vs 80.5% for blood types-A, B, or AB and blood type-O, respectively, P = .57). Following CD policy, blood type-O candidates had lower incidence of transplantation relative to other blood types (8-month incidences 86.3% vs 92.1%, respectively, P < .001), with a significantly lower adjusted hazard ratio for transplantation (0.67; 95% confidence interval, 0.54-0.82). Blood type-O candidates were more likely Hispanic and 'Other' race and had higher rates of waitlist removal or death following CD (6.0% vs 2.9%, P = .003). Among transplants performed prior to CD, 48% were blood type-O recipients compared to 40% post-CD, representing 138 fewer blood type-O transplants than expected. Type-O blood candidates had significant decline in prognosis relative to other blood groups following initial implementation of CD policy.
PMID: 40209905
ISSN: 1600-6143
CID: 5866952

Decreasing efficiency in deceased donor kidney offer notifications under the new distance-based kidney allocation system

Yu, Miko; Husain, Syed Ali; Adler, Joel T; Maclay, Lindsey M; King, Kristen L; Sahni, Prateek V; Cron, David C; Schold, Jesse D; Mohan, Sumit
Organ Procurement Organizations (OPOs) recover deceased donor kidneys and place them with matched recipients according to ranked match runs of patients, but offer notification practices differ across the OPOs and have changed following updates to allocation policy (kidney allocation system 250 [KAS250]). This national registry study used batch notification data to quantify time spent on kidney allocation and identify variations in batch notification practices across OPOs before and after the KAS250 allocation system era. Overall allocation time between the first and last offer notifications increased from a median of 1 to 7 hours under the KAS250 allocation system. For match runs of unplaced kidneys, allocation time increased from a median of 18 to 28 hours. Out-of-sequence (OOS) allocation, used by OPOs to limit nonutilization due to excess cold ischemia time, more than doubled in frequency between 2018 and 2022, with median time from first offer to initiation of OOS varying across OPOs from 0 to 47 hours. Increasing rates of organ nonutilization and the observed allocation practice differences based on organ quality demonstrate the urgent need for new approaches to achieve more efficient placement of hard-to-place kidneys. Data-driven approaches to optimize kidney allocation efforts will help ensure fairness in a system that currently allows for wide practice variation and frequent OOS allocation.
PMID: 40107362
ISSN: 1600-6143
CID: 5866942

Associations Among Circle-Based Kidney Allocation, Center Waiting Time, and Likelihood of Deceased-Donor Kidney Transplantation

Cron, David C; Kuk, Arnold E; Parast, Layla; Husain, S Ali; King, Kristen L; Yu, Miko; Mohan, Sumit; Adler, Joel T
RATIONALE & OBJECTIVE/OBJECTIVE:The kidney allocation system (KAS250), using circle-based distribution, attempts to address geographic disparities through broader sharing of deceased-donor kidney allografts. This study evaluated the association between KAS250 and likelihood of deceased-donor kidney transplantation (DDKT) among wait-listed candidates, and whether the policy has differentially affected centers with shorter versus longer waiting time. STUDY DESIGN/METHODS:Retrospective cohort study. SETTING & PARTICIPANTS/METHODS:160,941 candidates waitlisted at 176 transplant centers between March 2017 and March 2024. EXPOSURE/METHODS:KAS250 allocation policy. OUTCOME/RESULTS:Rate of DDKT. ANALYTICAL APPROACH/METHODS:Multivariable Cox regression, modeling KAS250 as a time-dependent variable. RESULTS:KAS250 was not independently associated with likelihood of DDKT overall (HR, 1.01 vs pre-KAS250 [95% CI, 0.97-1.04]). KAS250's association with likelihood of DDKT varied across centers from HR, 0.18 (DDKT less likely after KAS250), to HR, 17.12 (DDKT more likely) and varied even among neighboring centers. KAS250 was associated with decreased DDKT at 25.6% and increased DDKT at 18.2% of centers. Centers with previously long median waiting times (57+months) experienced increased likelihood of DDKT after KAS250 (HR, 1.20 [95% CI, 1.15-1.26]) whereas centers with previously short median waiting times (6-24 months; HR, 0.88 [95% CI, 0.84-0.92]) experienced decreased likelihood of DDKT. LIMITATIONS/CONCLUSIONS:Retrospective study of allocation policy changes, confounded by multiple changes over the study time frame. CONCLUSIONS:Association between KAS250 and DDKT varied across centers. For 1 in 4 centers, DDKT was less likely after KAS250 relative to pre-KAS250 trends. Candidates at centers with previously long waiting times experienced an increased likelihood of DDKT after KAS250. Thus, broader distribution of kidneys may be associated with improved equity in access to DDKT, but additional strategies may be needed to minimize disparities between centers. PLAIN-LANGUAGE SUMMARY/UNASSIGNED:This study examines how a recent policy change, KAS250, aimed at broadening the geographic sharing of deceased-donor kidneys, has impacted likelihood of kidney transplantation in the United States. Historically, kidney allocation occurred within local geographic boundaries, leading to unequal rates of transplantation across regions. KAS250, implemented in March 2021, replaced this system with a broader allocation radius of 250 miles around the donor hospital. Using national registry data, the study found that while there was no overall significant increase in the likelihood of transplantation nationally under KAS250, the policy's effect varied widely even among neighboring transplant centers. One quarter of centers experienced a decrease in the likelihood of DDKT after KAS250. In contrast, centers with longer pre-KAS250 waiting times experienced an increased likelihood of transplantation, suggesting some success in reducing disparities between centers. Ongoing surveillance will be needed to ensure KAS250 is meeting the intended aim of more equitably distributing organs.
PMCID:11930355
PMID: 39366540
ISSN: 1523-6838
CID: 5866912

Outcomes for Patients With a Deceased Donor Kidney Offer in the New Allocation System

Mohan, Sumit; Yu, Miko; Maclay, Lindsey M; Adler, Joel T; Huml, Anne M; Schold, Jesse D; Husain, S Ali
INTRODUCTION/UNASSIGNED:In the United States (US), disparities in access to kidney transplantation exist for waitlisted candidates with end-stage kidney disease. Meanwhile, changes in kidney allocation policy have been associated with a dramatic increase in the number of organ offers declined before an organ is successfully placed. METHODS/UNASSIGNED:We describe transplant and mortality rates for waitlisted candidates from 2015 to 2022 following these allocation changes. RESULTS/UNASSIGNED:Among 249,145 incident waitlisted adults, 180,039 received at least 1 offer and were included in the study. Of these, 37.7% received a deceased donor kidney allograft, 14.7% received a living donor allograft, 7.4% died while on the waiting list, 12.7% were removed, and 27.5% were still waitlisted by the study end period. Overall, candidates' median number of days to receiving their first offer declined from 20 (7-48) in 2015 to 5 (2-13) in 2022. Candidates who died while on the waiting list received a median of 25 (9-56) offers and candidates who were removed received a median of 22 (8-53) offers during the study period. The total number of offers generated by the match-run algorithm, including those from nonutilized kidneys, increased sharply from 7,911,688 offers in 2015 to 13,682,914 in 2019, and to 29,332,516 in 2022. CONCLUSION/UNASSIGNED:These findings emphasize the inefficiencies inherent in our current allocation algorithms and the need to rethink how waitlisted patients are prioritized for a given deceased donor organ in order to maximize the probability of appropriate utilization of lifesaving organs .
PMCID:12034855
PMID: 40303214
ISSN: 2468-0249
CID: 5866962

Embracing Complexity to Better Serve Pediatric Kidney Transplant Recipients [Comment]

Maclay, Lindsey M; Husain, S Ali
PMID: 38319991
ISSN: 1555-905x
CID: 5867972

Kidney function assessment using cystatin C and serum creatinine in heart transplantation recipients: Implications for valganciclovir dosing

Pinsino, Alberto; Jennings, Douglas L; Ladanyi, Annamaria; Duong, Phuong; Sweat, Austin O; Mahoney, Ian; Bohn, Bruno; Demmer, Ryan T; Takeda, Koji; Sayer, Gabriel T; Uriel, Nir; Leb, Jay S; Husain, Syed A; Mohan, Sumit; Colombo, Paolo C; Yuzefpolskaya, Melana
BACKGROUND:Among heart transplantation (HT) recipients, the accuracy of serum creatinine (sCr)-based estimated glomerular filtration rate (eGFR) may be limited by fluctuations in muscle mass. Cystatin C (cysC) is less influenced by muscle mass, but its levels may increase with obesity and steroid use. Herein, we (1) longitudinally compared eGFRcysC and eGFRsCr among HT recipients; (2) investigated the association of body mass index (BMI), steroid use, and muscle mass with discrepancies between eGFRs; and (3) explored the implications of eGFRcysC use on valganciclovir (VGC) dosing. METHODS:) were calculated with negative values corresponding to eGFRsCr > eGFRcysC and positive values to eGFRcysC > eGFRsCr. In a patient subset (n = 21), pectoralis muscle measures were obtained. RESULTS:values. The use of eGFRcysC would have led to VGC dose adjustment in 46% of samples, predominantly resulting in dose reduction. CONCLUSIONS:Among HT recipients, eGFRcysC and eGFRsCr markedly differ with implications for VGC dosing. The observed discrepancies may reflect changes in body composition and steroid use.
PMID: 39069163
ISSN: 1557-3117
CID: 5868042

Allocation and Utilization Patterns of Deceased Donor Kidneys for Preemptive Transplantation in the United States

King, Kristen L; Yu, Miko; Huml, Anne M; Schold, Jesse D; Husain, Syed Ali; Mohan, Sumit
PMID: 38284887
ISSN: 1533-3450
CID: 5867962

C3 Glomerulopathy Recurs Early after Kidney Transplantation in Serial Biopsies Performed within the First 2 Years after Transplantation

Tarragón, Blanca; Peleg, Yonatan; Jagannathan, Geetha; Sekulic, Miroslav; Chang, Jae-Hyung; Cohen, David J; Crew, Russell J; Dube, Geoffrey K; Fernandez, Hilda E; Husain, Syed Ali; Mohan, Sumit; Morris, Heather K; Appel, Gerald B; Jadav, Paresh; Santoriello, Dominick; Kudose, Satoru; Stokes, M Barry; Batal, Ibrahim; Bomback, Andrew S
BACKGROUND:C3 glomerulopathy (C3G), which encompasses C3GN and dense deposit disease (DDD), results from dysregulation of the alternative complement pathway. Data on disease recurrence after kidney transplantation are limited, and details on histologic features of recurrent C3G are scarce. We aimed to evaluate C3G recurrence in the allograft, with a focus on histologic presentation and progression. METHODS:We retrospectively analyzed 18 patients with native kidney failure attributed to C3G (12 C3GN and six DDD), who received a kidney transplant from January 2016 to January 2023. Demographic, genetic, clinical, and histologic data were studied. The NanoString 770 genes PanCancer Immune Profiling Panel was used for transcriptomic analysis. Disease recurrence was the primary outcome. RESULTS:During a median (interquartile range) follow-up period of 37 (18–56) months, C3G recurrence occurred in 16 (89%) patients (11 with C3GN and five with DDD) at a median (interquartile range) of 33 (13–141) days after transplantation. Over a third (38%) of recurrent cases were detected in protocol biopsies, and only 31% of patients presented with >300 mg/g of proteinuria. Recurrence in index biopsies was mainly established through a combination of immunofluorescence and electron microscopy findings, while it showed only subtle histologic alterations and no characteristic transcriptomic signals. Over time, histologic chronicity indices increased, but all the allografts were functioning at the end of follow-up. Patients with recurrence of C3GN and DDD showed overlapping immunofluorescence and electron microscopy findings and had similar recurrence rate and time to recurrence. CONCLUSIONS:Most of the patients with native kidney failure attributed to C3G developed disease recurrence very early after kidney transplantation, usually with minimal proteinuria, mild histologic alterations, and favorable short-term allograft survival. Immunofluorescence and electron microscopy played a crucial role in detecting early, subclinical recurrence of C3GN and DDD, which showed significant overlapping features.
PMCID:11321730
PMID: 39116277
ISSN: 1555-905x
CID: 5868052